Neutral impactStocks

Shilpa Medicare gets final approval for 5-day chemotherapy anti-nausea injection

CNBC-TV18 1 hr ago·11 Sept 2026, 9:03 am

Shilpa Medicare has received final approval to market its extended-release ondansetron injection in India, designed to provide anti-nausea protection for up to five days with a single dose. The approval comes as the drugmaker reports strong growth across key businesses.

Affected stocks

Neutral1 stock

Shilpa Medicare

SHILPAMED Neutral

₹939.90

Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.

Key takeaways

  • Concerns Shilpa Medicare (SHILPAMED).
  • Category: Stocks.

Why it matters

A routine update for Shilpa Medicare. Use the price and stock snapshot to gauge how the market is responding.

Summary & analysis by DocStoX. Full story at CNBC-TV18.

More Stocks news

More news

Explained: Why midcap and small-cap indices are outperforming NIFTY50 in 2026

Upstox · 14 min ago

Explained: Why is market bouncing back? Sensex recovers over 700 points from day’s low; Nifty back above 23,400

Economic Times · 31 min ago

Nifty trades below 23,400 level; auto share decline

Business Standard · 55 min ago

Nifty 50, Sensex Pare Losses as IT and FMCG Stocks Advance; Broader Markets Under Pressure

Dalal Street Investment Journal · 1 hr ago

Exclusive | Is the RBI worried about gold loans? Here's what the governor said

CNBC-TV18 · 1 hr ago

IndusInd Bank launches corporate credit card linked to OD and CC accounts

Indusind Bank₹993.30▲ 0.00%

CNBC-TV18 · 1 hr ago

Bank Nifty recovers 770 points from day’s low, turns flat as HDFC Bank, Yes Bank gain; PSU banks lag

HDFC Bank₹693.80▲ 0.00%

Moneycontrol.com · 1 hr ago

Does frequent buying and selling hurt returns? Coffee Can Investing fame Saurabh Mukherjea answers in Mint Extraclass

Mint · 1 hr ago

BSE share price fall 3% - Is it impact of NSE IPO price band announcement? Experts decode

Mint · 1 hr ago

Latest headlines

More news
Rajratan Global Wire

Rajratan Global Wire Limited — Analyst/Investor Meet Para A-XBRL

Rajratan Global Wire₹509.65▲ 0.00%

NSE · 9 min ago

Unichem Laboratories

Unichem Laboratories Limited — Updates

Unichem Laboratories₹532.70▲ 0.00%

NSE · 10 min ago

Bank OF India

Reserve Bank of India (Local Area Banks – Cash Reserve Ratio and Statutory Liquidity Ratio) Second Amendment Directions, 2026

Bank OF India₹141.00▲ 0.00%

RBI · 11 min ago

Techd Cybersecurity

TechD Cybersecurity Limited — Bagging/Receiving of orders/contracts (Sub-para 4-Para B)

Techd Cybersecurity₹601.40▲ 0.00%

NSE · 11 min ago

Network 18 Media & Investments Ltd eases for fifth straight session

Business Standard · 14 min ago

Jio Financial Services Ltd down for fifth straight session

JIO FIN Services₹230.25▲ 0.00%

Business Standard · 15 min ago

RBI partially cancels debt sale for first time in a year as rates spike

BusinessLine · 15 min ago

Reliance Industries Ltd drops for fifth straight session

Reliance Industries₹1,274.00▲ 0.00%

Business Standard · 15 min ago

Aggregated from third-party sources for research. Sentiment & impact are AI-generated, indicative, not advice.